Back
NexgenRx 10K Form
Sell
22
NXG.V
NexgenRx
Last Price:
0.26
Seasonality Move:
3.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NXG.V News And Ratings
See the #1 stock for the next 7 days that we like better than NXG.V
NXG.V Financial Statistics
Sales & Book Value
| Annual Sales: | $13.85M |
|---|---|
| Cash Flow: | $-3.3K |
| Price / Cash Flow: | 17.44 |
| Annual Sales: | $0.09 |
| Price / Book: | 2.86 |
Profitability
| EPS (TTM): | 0.00250 |
|---|---|
| Net Income (TTM): | $254.5K |
| Gross Margin: | $10.82M |
| Return on Equity: | 3.14% |
| Return on Assets: | 0.84% |
NexgenRx Earnings Forecast
Key NexgenRx Financial Ratios
- The Gross Profit Margin over the past 18 years for NXG.V is 78.14%.
- The Selling, General & Administrative Expenses for NXG.V have been equal to 9.20% of Gross Profit Margin.
- The Interest Expense is -8.71% of Operating Income.
- The Net Earning history of NXG.V is -2.40% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 12 years.
NexgenRx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSXV |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | NXG.V |
| Website: | nexgenrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.1 |
| Quick Ratio: | 0.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |